semaglutide phase 3 In the OASIS 4 trial, once-daily oral at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or CagriSema vs Tirzepatide: 23% Weight

Among 28,953 NAE reports associated with GLP-1 RAs, 19 distinct NAE signals were identified using reporting odds ratios (RORs), including dizziness, tremor, dysgeusia, lethargy, taste disorder, presyncope, parosmia, allodynia, and hypoglycemic unconsciousness, etc

The tools are coming

The agency will continue to work with state regulators, monitor the market, and take enforcement actions as necessary to prevent unsafe or fraudulent GLP-1 drugs from reaching U.S

Action of DPP-4 inhibitors

Formulated without dairy, soy, gluten, wheat, peanuts, tree nuts, eggs, fish, shellfish, artificial sweeteners, or preservatives